Research programme: targeted gene therapy - AAVP BiosystemsAlternative Names: RGD AAVP TNF
Latest Information Update: 28 Feb 2017
At a glance
- Originator AAVP Biosystems
- Class Antineoplastics; Gene therapies; Immunotherapies
- Mechanism of Action Gene transference; Tumour necrosis factor alpha stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer